ArticleClinical parkinsonism & related disorders2026
Successful use of continuous subcutaneous Foslevodopa/Foscarbidopa in Parkinson's disease with bipolar disorder without psychiatric destabilization.
Joanna Siuda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.